期刊文献+

GC测定枸橼酸坦度螺酮中的残留溶剂 被引量:1

Determination of Residual Organic Solvents in Tandospirone Citrate by GC
原文传递
导出
摘要 目的建立枸橼酸坦度螺酮原料药中甲醇、乙醇、异丙醇、乙酸乙酯、甲苯、N,N-二甲基甲酰胺残留量的测定方法。方法采用顶空气相色谱法,DB-624毛细管柱(30 m×0.32 mm,1.80μm),柱温为40℃,保持5 min,以20℃·min-1升至220℃,保持2 min;进样口温度为200℃;FID检测器温度为250℃;样品溶剂为二甲基亚砜。结果 6种溶剂均达到完全分离;在考察的浓度范围内线性关系良好,精密度和回收率良好。结论本方法能够准确测定枸橼酸坦度螺酮原料药中的残留溶剂。 OBJECTIVE To develop a headspace GC method for the determination of residual organic solvents such as methanol, ethanol, iso-propyl alcohol, ethyl acetate, methylbenzene, N,N-dimethylformamide in tandospirone citrate. METHODS Headspace GC was adopted using a DB-624 column(30m×0.32 mm, 1.80 μm), the column temperature was maintained at 40 ℃ for 5 min, then was raised to 220 ℃ at the rate of 20 ℃·min-1 and maintained at 220 ℃ for 2 min. The injection port temperature was 200 ℃; the FID detector temperature was 250 ℃; the sample was dissolved in DMSO. RESULTS Six residual solvents were separated completely. It was appeared to present a good linearity within the experimental concentration, and the precision and recoveries were good. CONCLUSION The method can be used for the determination of the residual solvents in tandospirone citrate.
作者 张悦杨 程智
出处 《中国现代应用药学》 CAS CSCD 2015年第6期721-724,共4页 Chinese Journal of Modern Applied Pharmacy
关键词 枸橼酸坦度螺酮 气相色谱法 顶空进样 残留溶剂 tandospirone citrate GC headspace sampling residual solvent
  • 相关文献

参考文献4

二级参考文献24

  • 1马景鑑,杨树源,魏伟,岳树源,钟跃,杨卫东,张大建,朱士广,朱涛,李萌,杨玉山,李牧,苏炳华,鄂正刚.盐酸法舒地尔治疗蛛网膜下腔出血所致脑血管痉挛的临床Ⅱ期试验研究[J].中华神经外科杂志,2006,22(1):36-40. 被引量:102
  • 2张琳,王超,董太和,直玉秋,朱柒锦,许冬青,王利宇.盐酸法舒地尔治疗急性脑梗死的临床研究[J].实用心脑肺血管病杂志,2006,14(5):362-363. 被引量:22
  • 3Shimizu H , Kariai N , Hirose A , et al. Interaction of SM23997 with serotonin receptors in rat baln[J]. Jpn J Pharmacol , 1998 , 46:311-314.
  • 4Barradell LB ,Fitton A. Tandosirone[J]. CNC Drug ,1996 ,5 : 147 - 153.
  • 5K Nishitsuji H To K Kodama etal.Tandospirone in the- Treatment of Generalised Anxiety Didorder and Mixed Anx2iety2Depression Result s of Comparatively High Dosage Trial.临床药物研究(日),2004,24(2):121-126.
  • 6徐济民.临床实用新药手册[M].上海:上海科学技术出版社,1997:146-147.
  • 7World Health Organization. Practical Chemotherapy ofMalaria: Report of WHO Scientific Group [R]. Geneva: WHO,1990.
  • 8FALADE C O, OGUNKUNLE O O’ DADA-ADEGBOLA H0,et al. Evaluation of the efficacy and safety ofartemether-lumefantrine in the treatment of acuteuncomplicated Plasmodium falciparum malaria in Nigerianinfants and children [J]. Malar J, 2008(7): 246-254.
  • 9FALADE C, MAKANGA M, PREMJI Z,et al. Efficacy andsafety of artemether-lumefantrine (Coartem) tablets (six-doseregimen) in African infants and children with acute,uncomplicated falciparum malaria [J]. Trans R Soc Trop MedHyg, 2005,99(6): 459-467.
  • 10YEUG S, PONGTAVOMPINYO W, HASTINGS I M, et at.Antimalarial drug resistance, artemisinin-based combinationtherapy,and contribution of modeling to elucidationg policychoices [J]. Am J Trop Med Hyg, 2004,71(Suppl 2):S179-S186.

共引文献9

同被引文献7

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部